Published in Thromb Res on January 01, 1979
Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials. Thromb Res (2010) 1.93
Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. J Lab Clin Med (1999) 1.82
The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry. J Thromb Haemost (2004) 1.62
Comparison of thrombelastography with common coagulation tests. Thromb Haemost (1981) 1.58
Shear-induced activation of platelets. J Biomech (1979) 1.52
Coagulation disorders in cancer. I. Clinical and laboratory studies. Cancer (1967) 1.32
The CD28 ligand, B7, enhances IL-2 production by providing a costimulatory signal to T cells. J Immunol (1992) 1.29
Symptomatology as an indicator of recurrent or metastatic breast cancer. Cancer (1979) 1.18
Preoperative and follow-up procedures on patients with breast cancer. Cancer (1980) 1.17
A guide to venous thromboembolism risk factor assessment. J Thromb Thrombolysis (2000) 1.10
Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost (1988) 1.03
Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost (2007) 1.02
Prevention and treatment of venous thromboembolism--International Consensus Statement. Int Angiol (2013) 1.01
Venous thromboembolism prophylaxis and risk assessment in medical patients. Semin Thromb Hemost (1991) 1.01
Diffusion of oxygen in plasma and blood. Adv Exp Med Biol (1976) 0.92
The identification of accelerated coagulability. Thromb Res (1976) 0.91
Electronic readout for three-channel thrombelastograph. J Med (1978) 0.89
The normal thromboelastogram and its interpretation. Semin Thromb Hemost (1995) 0.89
In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses. Thromb Haemost (1986) 0.88
Evaluation of therapeutic compression stockings in the treatment of chronic venous insufficiency. Dermatol Surg (1999) 0.88
Nonsurgical diagnosis and management of puerperal ovarian vein thrombophlebitis. Am J Obstet Gynecol (1979) 0.88
Omental anisakiasis: a rare mimic of acute appendicitis. Am J Clin Pathol (1983) 0.86
Thrombelastography of blood from subjects with chronic renal failure. Thromb Res (1987) 0.84
Risk factor assessment in the management of patients with suspected deep venous thrombosis. Int Angiol (2000) 0.84
Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical use. Int Angiol (2008) 0.83
Gastric operations and glucose homeostasis. Gastroenterology (1972) 0.83
Role of thromboelastography in evaluating other anticoagulant agents: warfarin and heparin-dihydroergotamine. Semin Thromb Hemost (1995) 0.83
Hematologic changes following burns. J Surg Res (1977) 0.83
Modified radical mastectomy. Cancer (1975) 0.82
Thromboelastographic changes in carcinoma: an animal model. J Med (1976) 0.82
Disseminated intravascular multiple systems activation (DIMSA) following thermal injury. J Trauma (1978) 0.81
Evaluation of oxygen extraction ratio as a physiologic transfusion trigger in coronary artery bypass graft surgery patients. Transfusion (2001) 0.81
Nonoperative extraction of retained common duct stones. Arch Surg (1976) 0.81
Evaluation of three methods used to identify accelerated coagulability. Thromb Res (1977) 0.80
Relationship between postsurgical fibrinolytic parameters and deep vein thrombosis in surgical patients treated with compression devices. Am Surg (1988) 0.80
Thromboelastography for the assessment of hypercoagulability during general surgery. Semin Thromb Hemost (1995) 0.80
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thrombo-embolism in high-risk patients. Eur J Vasc Endovasc Surg (2009) 0.80
Use of progressive pneumoperitoneum in the treatment of giant abdominal hernias. Am Surg (1978) 0.80
Finding the right fit: effective thrombosis risk stratification in orthopedic patients. Orthopedics (2000) 0.79
International perspective on venous thromboembolism prophylaxis in surgery. Semin Thromb Hemost (1991) 0.79
Alcohol inhibition of cyclic AMP-induced insulin release. Diabetes (1973) 0.79
Thrombelastographic patterns of ancrod and thrombin fibrin formation and dissolution. Thromb Res (1974) 0.79
Results of nonsurgical treatment of retained biliary calculi. Surg Gynecol Obstet (1980) 0.78
Thromboelastographic modifications induced by intravenous and subcutaneous heparin administration. Semin Thromb Hemost (1995) 0.78
Study of oxygen transport in skeletal muscle using an unsteady state method. Bibl Anat (1973) 0.78
Prevention of venous thromboembolism. European Consensus Statement, 1-5 November 1991, developed at Oakley Court Hotel, Windsor, UK. Int Angiol (1993) 0.78
Plasma cholinesterase activity in bank blood. Anesth Analg (1980) 0.78
The colon influences ileal resection diarrhea. Dig Dis Sci (1980) 0.78
Effects of hexahydrocoenzyme Q4 on murine muscular dystrophy. Proc Soc Exp Biol Med (1968) 0.77
Thrombosis prophylaxis using external compression. Surg Gynecol Obstet (1983) 0.77
Matching risk with treatment strategies in deep vein thrombosis management. Blood Coagul Fibrinolysis (1999) 0.77
Laboratory assays and duplex scanning outcomes after symptomatic deep vein thrombosis: preliminary results. J Vasc Surg (1996) 0.77
An unusual complication of minidose heparin therapy. Clin Orthop Relat Res (1976) 0.77
The haemostatic effectiveness of autologous platelet rich plasma sequestered after heparin administration and institution of cardiopulmonary bypass. Perfusion (1995) 0.77
Iatrogenic biliary tract complications: radiologic features and clinical significance. Radiographics (1991) 0.77
Gastric operations and glucose homeostasis. II. glucagon and secretin. Gastroenterology (1975) 0.77
Gas transfer and thrombogenesis in an annular membrane oxygenator with active blood mixing. Trans Am Soc Artif Intern Organs (1973) 0.77
Can combined (mechanical and pharmacological) modalities prevent fatal VTE? Int Angiol (2011) 0.76
The use of a Bayesian forecasting model in the management of warfarin therapy after total hip arthroplasty. J Arthroplasty (1999) 0.76
In vitro testing of surface thrombogenicity using the thrombelastograph. Res Commun Chem Pathol Pharmacol (1976) 0.76
Modifications of plasma levels of tissue factor pathway inhibitor and endothelin-1 induced by a reverse Trendelenburg position: influence of elastic compression--preliminary results. J Vasc Surg (1995) 0.76
Altered coagulability in cancer patients. CA Cancer J Clin (1982) 0.76
The effect of intravenous fixed-dose heparin during total hip arthroplasty on the incidence of deep-vein thrombosis. A randomized, double-blind trial in patients operated on with epidural anesthesia and controlled hypotension. J Bone Joint Surg Am (1991) 0.75
Follow-up adjuvant chemotherapy and chemoimmunotherapy for stage II and III carcinoma of the breast. Cancer (1982) 0.75
Biliary peritoneal grafts. Am Surg (1980) 0.75
Assessment of coagulation system activation using spot urine measurements. Blood Coagul Fibrinolysis (1999) 0.75
Treatment of breast carcinoma recurrent after adjuvant chemoimmunotherapy. J Surg Oncol (1984) 0.75
Application of thromboelastography in other medical and surgical states. Semin Thromb Hemost (1995) 0.75
Laboratory monitoring of continuous intravenous heparin therapy. Thromb Res (1983) 0.75
Etiology, diagnosis, and treatment of recovery room bleeding/hemorrhage. Heart Lung (1985) 0.75
Venous thromboembolism after hospital discharge. Semin Thromb Hemost (1993) 0.75
Serum glucose, insulin, total, pancreatic and enteric glucagon in dogs before and after pancreatectomy, in patients with gastrectomy and pyloroplasty and in diabetic children. Effects of insulin and of secretin. Mater Med Pol (1977) 0.75
Symposium on the future of philanthropic foundations. Summing up. Ciba Found Symp (1975) 0.75
Your attitudes toward treating drinking problems. Med Times (1977) 0.75
Contact activation of heparinized plasma. Thromb Res (1974) 0.75
A new forceps for removal of biliary tract stones. Surg Gynecol Obstet (1985) 0.75
Neutralization of heparin by cellular blood elements. Thromb Res (1975) 0.75
Adjuvant chemotherapy for stage II and III breast carcinoma. JAMA (1980) 0.75
Demography and birth control. IPPF Med Bull (1974) 0.75
Gallbladder disease: current trends and treatments. Am J Nurs (1980) 0.75
Coagulation changes in the newborn with respiratory failure. Thromb Res (1980) 0.75